Member Info for Chrishar

Ghia I don't think you can extrapolate the need for testing based on your example. The most important thing in the winter is to again protect the most vulnerable. Take care homes and nursing homes - there will need to be constant repeat testing of staff and residents up and down the country. We also know that there's going to be enormous need for testing to keep the travel industry afloat.

There are rumblings now that even those that only suffered very minor symptoms are seeing lung damage which could potentially be long lasting. Soon there should be therapeutics on the market that can be taken right at the onset of infection (sng001 perhaps?!). Knowing that even if you're fit the virus might cause you chronic health complications, wouldn't you want to be tested and therefore receive treatment asap?

Roche diagnostics is a subsidiary of Roche, the second biggest company on the Swiss stock exchange from what I can see at $280 billion...

Don't think we'll be buying them!

I hear you. This *really* will be my last post on here today.

All I've been seeking is a bit of honesty. This board has been a fantastic resource and posters seemed to be able to reflect on the good and the bad. It now just seems that the bad is breezily ignored or excused and the goalposts constantly moved. Yesterday Richard's video should have assuaged many fears investors had and the rise into results was expected. But it hasn't come...

Fine, no one on here owes anything to anyone but it's a shame that we're at one third the broker forecast pre-results and nobody wants to admit that it's a bit of a red flag.

This'll be my last post on the matter. I'm simply saying it feels like you're being disingenuous or completely blinkered due to the effort and time you've put in to this investment.

This might still turn out to be an excellent investment but you've always got a new reason for why it doesn't matter that we are consistently below where you predicted we'd be share price wise. Previously you made a point of the II being a distressed seller to legitimise the selloff. You also got all excited to find out which IIs had taken them off their hands. Now it seems all IIs are not interested in the future direction of the share price?

I'm trying not to read too much into the sp but I think it's understandable to be getting a bit wobbly now.

I was very happy to accept the distressed seller argument for why we were falling before. But now? Acacia selling down further isn't a vote of confidence...

Danny, I haven't seen any even half positive posts from you in a while now. It's nice of you to give your time as the self-appointed french poster but if you're just here to be negative then I'm pretty sure we can cope without you.

You're being genuinely misleading here seadoc. This is an AIM share, not a blue chip. There is the potential to drop 50% quickly from highs, there is the potential to rise 100% off the back of some exceptional news.

The market is aware of the 10 million tests but it is not expecting them to sell them all. If this update shows new large contracts in place and revenue now up to £180m then you really believe £2.80 is where this'll settle at best?

This.does.look.positive.

I concede to your superior knowledge of AIM (no sarcasm intended).

I have consumed the well researched posts on here with great appetite and have also memorised the predictions. I am merely pointing out that whatever way you want to swing it the sp has been far more sluggish and disappointing than the majority on here had predicted.
You are one of the first on here to post a comment when the Ask rises...

We are days away from the COPD results. We are not far away from the covid hospital trial results. Upon success forecasts right up to about £5 a share have been made. There is also lots of data to give us optimism.

It is fair to assume that investors in general are not as taken with this company and the outlook as we are, is it not?

It's a legitimate question. Posters on here happily go around quoting the £1.20 before results figure whilst the sp moves closer to 0 than £1.20...

We were all very much expecting a speedy and significant rise once the selling slowed down. It's fair to question why this is not happening.

It so clearly says 4 April. Did you send the wrong link? I mean, c'mon.

If there was some evidence that we had sold all 10 million and were short of supply there is no chance we'd be sitting on a sp under £4.

I don't think that matters Danny. When I say that we should sell 10 million tests a month, I am not being anal about it. If we sell on average 8 million at £7 a test we're still looking at £56m a month from our own tests alone.

That we have some stock available to send out promptly doesn't really tell us anything right now.

The past month has been frustrating as the wider markets recovered and novacyt has fallen. However it's looking increasingly likely that markets are going to falter in the short to medium term. As the date for widescale vaccination programmes gets pushed further and further back and the chance of another lockdown once we hit flu season becomes ever more evident, investors are going to panic and there will be flight from blue chip companies again.

This is one of the few companies that will benefit. It has no debt now, minimal overheads, and revenue that's about to exceed the mcap after just four months of covid. If that isn't a buy signal I really don't know what is?

Judging by the monthly updates so far they can fall either side of the last day of the month. Monday is the penultimate day of the month so technically yes, it could definitely land Monday.

The only way an update is going to hurt the share price is if Graham has seriously over promised and under delivered.

Ramping up production to ten million and then failing to sell those tests straight off the bat with the pandemic getting ever worse globally - would be a massive fail.

Please please please let the interview be discussed on here without the unrelated bickering in between. It's completely drowning out all the useful posts.

3-5 trading days from update if in keeping with previous updates.

Please correct me if I'm wrong with that claim.

It would be great to see £0.60 before results for a bit of a boost but realistically for us LTHs it doesn't really make a difference.